Key Insights

Highlights

Treatment Research

2 treatments under study, led by Paperbased Isp Control Group

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Paperbased Isp Control Group1
  • Rhapsode Capable Platform Intervention Group1

Active Sponsors

  • Catholic University of Health and Allied Sciences1
  • Stanford University1
  • London School of Hygiene and Tropical Medicine1
  • National Institutes of Health (NIH)1

Top Investigators

Related Conditions

  • Computerassisted Instruction1
  • Severe Malaria1
  • Severe Pneumonia1
  • Newborn Resuscitation1
  • Simulation Training1

Activity Timeline